top of page
IMG_5716.HEIC

SYNGENEIC
MOUSE
MODELS

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We take a personal interest in our clients and their studies.  

In a syngeneic mouse model, the tumor cell line is derived from the same species as the host animal. Syngeneic models can thus test the efficacy of immuno-oncology agents as single therapies, or in combination with other anti-cancer drugs. Please see list of available models below. 
Other options include:
  • Custom study designs
  • Fluorescent imaging
  • MTD studies
  • Pre-clinical drug formulation
  • Tumor collection, organ collection, histology
  • Pharmacodynamic studies (e.g. ELISA, Luminex, PCR, sequencing, flow cytometry)

 Please see below for our available models or to request a quote

SYNGENEIC 
cell lines 

Cell line
Organ
Weeks from stratification to termination (average)
Growth Curve
4T1
Breast
4
A20
Blood
N/A
AB22
Lung
N/A
B16-F10
Skin
2
CT26
Colon
2.5
CT26.CL25
Colon
2.5
Cloudman S91
Skin
N/A
Colon-26 (MC26)
Colon
4
D4M3A
Skin
2
EMT6
Breast
5
Lewis Lung LLC1
Lung
3
MBT-2
Bladder
5.5
MC38
Colon
4
P388
Blood
N/A

*Other cell lines are possible, please contact us about your cell line of choice

Rincon Bio in vitro 1.jpg

QUOTE REQUEST FORM

syngeneic mouse models

Please fill out the form below

We will respond with a quote within one business day

Route of Administration?
Other options:
Is the planned study part of a grant application?

MEET OUR SCIENTIFIC DIRECTOR

Bret Stephens, PhD
  • LinkedIn Social Icon

Dr. Stephens has a broad in vivo biology background that comes from twenty years of involvement in cancer drug discovery in both academic and pharmaceutical industry settings.

 

Dr. Stephens received his PhD in Molecular Biology from the University of Arizona.

 

Previous to joining Rincon Bio, Dr. Stephens worked at Tolero Pharmaceuticals, Huntsman Cancer Institute (University of Utah), and the BioDesign Institute (Arizona State University), where he focused on cancer small molecule drug development.

ABOUT US

Founded in 2013, Rincon Bio is a pre-clinical CRO focusing on in vivo cancer efficacy studies, both allogeneic (human cell models) and syngeneic (immunotherapy models).

 

The staff at Rincon Bio have performed hundreds of efficacy studies for pharmaceutical researchers across the United States and Europe, both in industry and in academia. We've worked in the world of small, agile, start-up pharma, which gives us a unique perspective as a CRO.  We appreciate that your priorities change quickly, and you need a partner that can adapt along with you.  Furthermore, we can initiate most efficacy studies more quickly than any other CRO. 

 

We understand the importance of transparency and communication: at Rincon Bio, our clients are assigned a single point-of-contact, who is responsible for managing their study from conception to completion. 

Rincon Bio is a US-based organization, born from a desire to simplify the process of running cancer efficacy studies, and to provide domestic quality at competitive prices. We are The Cancer Model CRO - we believe in doing one thing, and doing it well.  

 

If you do decide to run your study at Rincon Bio, the process will be easy, streamlined, and pleasant.  

 

Email: info@rinconbio.com
Tel:  760-713-6613

Utah: 

3900 N Traverse Mountain Blvd

Suite 100

Lehi, UT 84043

California: 

3156 Vista Way, Suite 220

Oceanside, CA 92056

 

CONTACT US
bottom of page